116 related articles for article (PubMed ID: 17912030)
1. Copy-number variants in patients with a strong family history of pancreatic cancer.
Lucito R; Suresh S; Walter K; Pandey A; Lakshmi B; Krasnitz A; Sebat J; Wigler M; Klein AP; Brune K; Palmisano E; Maitra A; Goggins M; Hruban RH
Cancer Biol Ther; 2007 Oct; 6(10):1592-9. PubMed ID: 17912030
[TBL] [Abstract][Full Text] [Related]
2. ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion.
Arts HH; Lynch L; Grafodatskaya D; Eng B; Malloy L; Duck J; White R; Woodside C; Bell K; Zbuk KM; McCready E
Cancer Genet; 2020 Jan; 240():1-4. PubMed ID: 31671381
[TBL] [Abstract][Full Text] [Related]
3. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.
Lucito R; Healy J; Alexander J; Reiner A; Esposito D; Chi M; Rodgers L; Brady A; Sebat J; Troge J; West JA; Rostan S; Nguyen KC; Powers S; Ye KQ; Olshen A; Venkatraman E; Norton L; Wigler M
Genome Res; 2003 Oct; 13(10):2291-305. PubMed ID: 12975311
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
5. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
Heidenblad M; Lindgren D; Veltman JA; Jonson T; Mahlamäki EH; Gorunova L; van Kessel AG; Schoenmakers EF; Höglund M
Oncogene; 2005 Mar; 24(10):1794-801. PubMed ID: 15688027
[TBL] [Abstract][Full Text] [Related]
6. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.
Bashyam MD; Bair R; Kim YH; Wang P; Hernandez-Boussard T; Karikari CA; Tibshirani R; Maitra A; Pollack JR
Neoplasia; 2005 Jun; 7(6):556-62. PubMed ID: 16036106
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of pancreatic cancer using microarray-based techniques.
Harada T; Chelala C; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2009; 9(1-2):13-24. PubMed ID: 19077451
[TBL] [Abstract][Full Text] [Related]
8. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
Chen S; Auletta T; Dovirak O; Hutter C; Kuntz K; El-ftesi S; Kendall J; Han H; Von Hoff DD; Ashfaq R; Maitra A; Iacobuzio-Donahue CA; Hruban RH; Lucito R
Cancer Biol Ther; 2008 Nov; 7(11):1793-802. PubMed ID: 18836286
[TBL] [Abstract][Full Text] [Related]
9. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
10. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
11. Screening for common copy-number variants in cancer genes.
Tyson J; Majerus TM; Walker S; Armour JA
Cancer Genet Cytogenet; 2010 Dec; 203(2):316-23. PubMed ID: 21156252
[TBL] [Abstract][Full Text] [Related]
12. High-resolution characterization of the pancreatic adenocarcinoma genome.
Aguirre AJ; Brennan C; Bailey G; Sinha R; Feng B; Leo C; Zhang Y; Zhang J; Gans JD; Bardeesy N; Cauwels C; Cordon-Cardo C; Redston MS; DePinho RA; Chin L
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9067-72. PubMed ID: 15199222
[TBL] [Abstract][Full Text] [Related]
13. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
Heidenblad M; Schoenmakers EF; Jonson T; Gorunova L; Veltman JA; van Kessel AG; Höglund M
Cancer Res; 2004 May; 64(9):3052-9. PubMed ID: 15126341
[TBL] [Abstract][Full Text] [Related]
15. BRCA2 germline mutations in familial pancreatic carcinoma.
Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
[TBL] [Abstract][Full Text] [Related]
16. Deletions and duplications of developmental pathway genes in 5q31 contribute to abnormal phenotypes.
Rosenfeld JA; Drautz JM; Clericuzio CL; Cushing T; Raskin S; Martin J; Tervo RC; Pitarque JA; Nowak DM; Karolak JA; Lamb AN; Schultz RA; Ballif BC; Bejjani BA; Gajecka M; Shaffer LG
Am J Med Genet A; 2011 Aug; 155A(8):1906-16. PubMed ID: 21744490
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide rare copy number variation screening in ulcerative colitis identifies potential susceptibility loci.
Saadati HR; Wittig M; Helbig I; Häsler R; Anderson CA; Mathew CG; Kupcinskas L; Parkes M; Karlsen TH; Rosenstiel P; Schreiber S; Franke A
BMC Med Genet; 2016 Apr; 17():26. PubMed ID: 27037036
[TBL] [Abstract][Full Text] [Related]
18. Identification of germline genomic copy number variation in familial pancreatic cancer.
Al-Sukhni W; Joe S; Lionel AC; Zwingerman N; Zogopoulos G; Marshall CR; Borgida A; Holter S; Gropper A; Moore S; Bondy M; Klein AP; Petersen GM; Rabe KG; Schwartz AG; Syngal S; Scherer SW; Gallinger S
Hum Genet; 2012 Sep; 131(9):1481-94. PubMed ID: 22665139
[TBL] [Abstract][Full Text] [Related]
19. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
20. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
